Health Legislation

This Decree approves the amended statutes of the Beninese pharmaceutical regulatory agency, now named “Beninese Agency for Medicines and other Health Products”.

The decree defines the health benefit package of the universal health insurance scheme.

These regulations were developed in the exercise of the powers conferred by sections 24, 30, 46)2), 47(5) and 50(1) of the Social Health Insurance Act, 2023, by the Cabinet Secretary for Health, in consultation with the Board for the Social Health Authority.

This Order provides for the creation, organization and operation of the program called the National Health Education Programme.

The Decree establishes the health benefit package covered under the Universal Health Insurance. The decree was published on 25 November 2023 in the Official Journal.

This Law amends Articles 1, 2, 3, 5, 6, 8, 9, 10, 11, 13, 14, 16, 18, 20, 21, 23, 25, 27, 31, 33, 36, 37, 38, 42, 45, 47, 51, 51, 52, 53, 54, 55, 56, 65, 66, 80 and 86 of the Law No 2020-37 protecting the health of people in the Republic of Benin.

The Decree specifies the application of certain provisions of the law establishing the Universal Health Insurance Scheme, such as affiliation and registration, the insured person's card, care benefits covered, the assumption of responsibility for benefits, health care providers, among other aspects.

The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.

This Decree establishes and fixes the rules of organization and operation of the Senegalese Pharmaceutical Regulatory Agency (ARP)

This Act repeals and replaces the Public Health Act of 1960, provides for the promotion, protection and improvement of public health and well-being in Sierra Leone, provides for the protection of individuals and communities from public health risks, provides for the prevention and control of the spread of infectious diseases, provides for local government and community participation in protecting public health, provides for early detection and prompt response to diseases and public health threats and provides for other related matters.

This document provides the benefits package of the National Health Insurance Scheme as offered to its beneficiaries through private health providers.

The purpose of this law is to organize the protection of the health of the population, and to define the obligations imposed on citizens in the event of communicable, non-communicable, contagious diseases or epidemics. It applies to any person living in the Republic of Benin or entering Benin territory.

The law creates the Burundian Authority for the Regulation of Medicines for Human Use and Food. The authority's general aim is to protect public health by promoting the quality and safety of products such as prefabricated and ambient foods, medicines for human use, cosmetics and dietary products containing active ingredients, herbal medicines, traditional medicines, and medical devices, among others.

These Instructions establish the methodology to determine the community-based health insurance benefit package.

This law establishes a universal health insurance in the Togolese Republic.

The Decree approves the Organic Statute of the Autoridade Nacional Reguladora de Medicamento (The National Medicines Regulatory Authority). The purpose of this Decree is to define the rules governing the organization, management and operation, as well as the powers of its bodies.

This Act establishes the Pharmacy and Medicines Regulatory Authority; provides for the functions and powers of the Authority; and provides for matters connected therewith and incidental thereto.

This Act lays down the fundamental provisions and principles and aims to give concrete form to the rights and duties of the population in matters of health. Its purpose is to ensure the prevention, protection, maintenance, restoration and promotion of people's health. It was published in the Official Journal on 29 July 2018.

This Law establishes the fundamental principles relating to the organization of public health in the Democratic Republic of the Congo.

The objective of the law is to establish an institutional framework for regulating the pharmaceutical sector to ensure market approval and use of pharmaceutical products that are accessible, safe, efficient, and of appropriate quality (art.2). It notably establishes the Authority for pharmaceutical regulation (Autorité Ivoirienne de Regulation Pharmaceutique - AIRP) and addresses its mandates (chapter 1).